The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
High-dose methotrexate with and without rituximab for the treatment of newly diagnosed primary CNS lymphoma: Johns Hopkins Hospital experience.
Matthias Holdhoff
No relevant relationships to disclose
Guneet Sarai
No relevant relationships to disclose
Ahmed Abdelaziz
No relevant relationships to disclose
David Bonekamp
No relevant relationships to disclose
Stuart A. Grossman
No relevant relationships to disclose
Xiaobu Ye
No relevant relationships to disclose